Modulators of indoleamine 2,3-dioxygenase

US10472336B2 · kind B2 · utility

Assignee

• GlaxoSmithKline Intellectual Property Development Limited · GB

Inventors

• Pek Yoke Chong · Morrisville, US
• Martha Alicia De La Rosa · Morrisville, US
• Hamilton D. Dickson · Morrisville, US
• Wieslaw Mieczyslaw Kazmierski · Durham, US
• Vicente Samano · Morrisville, US
• Vincent Wing-Fai Tai · Темневкий пруд, US

Key dates

• Filing date: Sep 22, 2016
• Grant date: Nov 12, 2019
• Expiry date: Sep 22, 2036

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07C2601/16
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of HIV; including the prevention of the progression of AIDS and general immunosuppression.